In a safety review, the FDA identified 14 cases of seizures linked to vitamin B6 deficiency in patients taking carbidopa/levodopa-containing drugs.

The firm intends to launch the trial based on positive results from an open-label Phase I/IIa trial of sasineprocel, previously known as ANPD001.

Northwestern Medicine scientists have discovered that an FDA-approved compound promotes neuroprotective effects in experimental models of Parkinson's disease. The compound, N-acetyl-L-leucine (NALL), ...

Researchers engineered a two-strain microbial system that converts PET-derived terephthalic acid into levodopa, overcoming key bottlenecks in transport and enzyme inhibition. The proof-of-concept ...

A growing body of research into Parkinson’s disease is challenging the assumption that the condition looks the same in every ...

L-leucine, an FDA-approved compound, exerts neuroprotective effects in Parkinson’s disease models. By reducing alpha-synuclein aggregation and restoring dopamine signaling, NALL targets multiple ...

Nobody likes to see plastic bottles overflowing in bins and rattling around the streets. These single-use receptacles are a prime target in tackling the plastic crisis, but what if we’ve been ...

Thus far, 7,600 genetic diseases have been identified and more are being discovered every year. Read more at straitstimes.com ...

Where drinking water comes from and what it contains may affect Parkinson's disease risk, a recent study suggests.

Japan has approved ground-breaking stem cell treatments for Parkinson’s and severe heart failure, one of the manufacturers and media reports said yesterday, with the therapies expected to reach ...

Japan has approved ground-breaking stem-cell treatments for Parkinson's and severe heart failure, one of the manufacturers and media reports said Friday, with the therapies expected to reach patients ...